|
US5747639A
|
|
Use of hydrophobic interaction chromatography to purify polyethylene glycols
|
|
AU4424996A
|
|
A tgf-beta superfamily type ii receptor having binding affinity
|
|
WO9611213A1
|
|
Dimeric il-4 inhibitors
|
|
CA2190752A1
|
|
Modified insulin-like growth factors
|
|
CA2160154A1
|
|
Methods of using insulin-like growth factor binding proteins
|
|
CA2154078A1
|
|
Wound healing composition
|
|
AU6048294A
|
|
Modified insulin-like growth factors
|
|
SG48115A1
|
|
Inhibition of retrovirus infection
|
|
CA2135397A1
|
|
T-cell membrane inducing factors
|
|
CA2118119A1
|
|
Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
|
|
US6132990A
|
|
Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
|
|
RU2113482C1
|
|
Protein factor, nucleotide sequence, method of protein factor preparing
|
|
EP0373168A1
|
|
Polypeptide useful in diagnosis of coccidia infection and recombinant-dna methods for manufacturing same
|
